Previsioni di mercato immunoistochimica per il Sud America fino al 2028 – Impatto del COVID-19 e analisi regionale per applicazione (diagnostica e test antidroga), prodotto (anticorpi, apparecchiature, reagenti e kit) e utente finale (ospedali e laboratori diagnostici, istituti di ricerca e altri) )

TIPRE00025751 | Pages: 140 | Biotechnology | Nov 2021 | Type: Regional | Status: Published

Introduzione al mercato

I principali paesi inclusi nell\'analisi per SAM includono Argentina, Brasile e resto del SAM. Il Brasile ha guidato il mercato nel 2021. Il Brasile è la più grande economia dell’America Latina e il suo settore sanitario è distribuito tra soggetti pubblici e privati. La produzione locale è limitata ai beni di consumo e agli articoli ordinari, e ci sono pochi produttori di dispositivi ad alta tecnologia. Pertanto, il Brasile importa molti dispositivi medici da altri paesi. Il cancro è una delle principali malattie epidemiche e il numero di persone a cui è stato diagnosticato un cancro è raddoppiato negli ultimi tre decenni. Secondo i dati presentati in un articolo, Revista Brasileira de Cancerologia 2018, nel corso del 2018-2019 ci sarebbero circa 600.000 nuovi casi di cancro nel Paese. Secondo il rapporto VanEck Research pubblicato nel 2017, il mercato della diagnostica in Brasile è in crescita. Ci sono circa 22.000 laboratori sparsi in tutto il Brasile. I primi quattro attori del mercato sono i primi quattro partecipanti al mercato: Diagnósticos da América SA (DASA), Fleury SA, Centro de Imagem Diagnósticos SA (Alliar) e Instituto Hermes Pardini SA (Hermes Pardini). Il fattore chiave per la crescita del mercato diagnostico è il crescente invecchiamento della popolazione. Il rapporto menziona inoltre che il 52% della popolazione totale avrà 45 anni o più entro il 2050. Sulla base dei fattori sopra menzionati, è probabile che il Brasile offra varie opportunità di crescita per gli operatori del mercato dell\'immunoistochimica durante il periodo di previsione.

I paesi della SAM, in particolare il Brasile, sono fortemente colpiti dall\'epidemia di COVID-19. L’epidemia ha avuto gravi ripercussioni sui servizi medici nella regione. Inoltre, le nazioni sono famose per il turismo medico, anch’esso influenzato dalla pandemia. Brasile, Argentina, Uruguay, Cile, Perù e Colombia sono colpiti dalla seconda ondata dell’epidemia di COVID-19. Secondo Worldometer, al 3 settembre 2021, il Brasile ha riportato 558.597 vittime e 21 milioni di nuovi casi di COVID-19. Ci sono stati 5,2 milioni di nuovi casi in Argentina, segno della seconda ondata di epidemia di COVID-19. Si prevede che SAM imporrà un secondo blocco, che alla fine ostacolerà il settore sanitario nella regione. Brasile, Argentina, Uruguay, Cile, Perù e Colombia sono preoccupati dalla seconda ondata. Tra i quali il Brasile ha registrato la maggior parte dei decessi.

Panoramica e dinamiche del mercato

Si prevede che il mercato dell\'immunoistochimica SAM crescere da 129,48 milioni di dollari nel 2021 a 202,68 milioni di dollari entro il 2028; si stima che crescerà a un CAGR del 6,6% dal 2021 al 2028. L\'immunoistochimica (IHC) si riferisce a un\'importante applicazione di anticorpi monoclonali e policlonali per la determinazione tissutale e la distribuzione di antigeni di particolari malattie. Viene utilizzato principalmente per rilevare diversi disturbi infettivi come la dengue, l\'epatite, il virus dell\'immunodeficienza umana (HIV). Anche le condizioni mediche croniche come l\'obesità, il cancro, il diabete, le malattie cardiache e l\'ictus sono considerate le principali applicazioni dell\'immunoistochimica che aiuta nella diagnosi di queste malattie. Il diabete prevale a un tasso elevato nella popolazione geriatrica di tutta la regione. La prevalenza del diabete è maggiore nelle persone in sovrappeso e obese. I tassi di obesità sono aumentati rapidamente nelle economie sviluppate e in via di sviluppo in tutta la regione. Fattori come lo stile di vita malsano e la vita sedentaria sono tra i principali responsabili dell’aumento del numero di individui obesi. Le malattie cardiovascolari (CVD) comprendono malattie cerebrovascolari, malattie cardiache reumatiche, malattie coronariche e altre condizioni. È la causa più significativa di morbilità e mortalità in tutta la regione. Inoltre, si è verificato un aumento dell’incidenza del cancro e dei tassi di mortalità in tutta la regione, rendendo il cancro la principale causa di morte. Si prevede che un tale aumento dell\'incidenza di malattie croniche e infettive creerà una domanda di test immunologici nella regione SAM.

Segmenti chiave del mercato

In termini di prodotto, il segmento degli anticorpi ha rappresentato la quota maggiore del mercato dell\'immunoistochimica SAM nel 2020. In termini di applicazione, il segmento della diagnostica ha detenuto una quota di mercato maggiore del mercato dell\'immunoistochimica SAM nel 2020. Inoltre, nel 2020, il segmento degli ospedali e dei laboratori diagnostici deteneva una quota maggiore del mercato dell\'immunoistochimica SAM in base all\'utente finale.  

Principali fonti e aziende elencate

Alcune delle principali fonti primarie e secondarie a cui si fa riferimento per la preparazione di questo rapporto sul mercato dell\'immunoistochimica SAM sono siti Web aziendali, relazioni annuali, relazioni finanziarie, documenti governativi nazionali e database statistici, tra gli altri. Le principali società elencate nel rapporto sono Abcam plc; Agilent Technologies, Inc.; Bio SB; BIO-RAD LABORATORI INC.; Danaher; F. HOFFMANN-LA ROCHE LTD.; MERCK KGaA; PerkinElmer Inc.; e THERMO FISHER SCIENTIFIC INC.

Motivi per acquistare il rapporto

< ul>
  • Comprendere il panorama del mercato dell\'immunoistochimica SAM e identificare i segmenti di mercato che hanno maggiori probabilità di garantire un forte rendimento
  • Stare al passo con la concorrenza comprendendo il panorama competitivo in continua evoluzione per il mercato dell\'immunoistochimica SAM
  • Pianificare in modo efficiente operazioni di fusione e acquisizione e accordi di partnership nel mercato dell\'immunoistochimica SAM identificando i segmenti di mercato con le vendite probabili più promettenti
  • Aiuta a prendere decisioni aziendali consapevoli dall\'analisi perspicace e completa delle prestazioni del mercato di vari segmenti del mercato immunoistochimico SAM
  • Ottieni previsioni sulle entrate del mercato per vari segmenti dal 2021 al 2028 nella regione SAM.
  • Segmentazione del mercato dell\'immunoistochimica SAM

    Mercato dell\'immunoistochimica SAM - Per prodotto

    • Attrezzatura
      • Sistemi di colorazione dei vetrini
      • Sistemi di microarray per tessuti
      • Trattamento dei tessuti Sistemi
      • Scanner per vetrini
      • Altre apparecchiature
    • Anticorpi
      • Anticorpi primari
      • Anticorpi secondari
    • Reagenti
      • Coloranti istologici
      • Reagenti bloccanti e fissativi
      • Substrati cromogenici
      • Reagenti di fissaggio
      • Stabilizzanti
      • Solventi organici
      • Enzimi proteolitici
      • Diluenti
    • Kit

    Mercato dell\'immunoistochimica SAM - per applicazione

    • Diagnostica
      • Cancro
      • Malattie infettive
      • Malattie autoimmuni
      • Diabete mellito
      • Malattie nefrologiche
      • Altro
    • Test antidroga

    Mercato dell\'immunoistochimica SAM - Per utente finale

    • Ospedali e laboratori diagnostici
    • Istituti di ricerca
    • Altro

    Mercato dell\'immunoistochimica SAM - Per paese

    • Brasile
    • Argentina
    • Resto di SAM

    Mercato immunoistochimico SAM - Profili aziendali

    • Abcam plc
    • Agilent Technologies, Inc.
    • Bio SB
    • BIO-RAD LABORATORIES INC.
    • Danaher
    • F. HOFFMANN-LA ROCHE LTD.
    • MERCK KGaA
    • PerkinElmer Inc.
    • THERMO FISHER SCIENTIFIC INC.

    TABLE OF CONTENTS

    1.             Introduction

    1.1       Scope of the Study

    1.2       The Insight Partners Research Report Guidance

    1.3       Market Segmentation

    1.3.1        SAM Immunohistochemistry Market – By Product

    1.3.2        SAM Immunohistochemistry Market – By Application

    1.3.3        SAM Immunohistochemistry Market – By End User

    1.3.4        SAM Immunohistochemistry Market – By Country

    2.             Key Takeaways

    3.             Research Methodology

    3.1       Coverage

    3.2       Secondary Research

    3.3       Primary Research

    4.             SAM Immunohistochemistry Market – Market Landscape

    4.1       Overview

    4.2       SAM PEST Analysis

    4.3       Experts Opinion

    5.             SAM Immunohistochemistry Market – Key Market Dynamics

    5.1       Market Drivers

    5.1.1        Rising Incidences of Chronic and Infectious Diseases

    5.1.2        Increasing R&D Investments by Biotechnology & Biopharmaceutical Companies

    5.2       Key Market Restraints

    5.2.1        Limitations Associated with Immunohistochemistry

    5.3       Key Market Opportunities

    5.3.1        Development Opportunities in Emerging Countries

    5.4       Future Trends

    5.4.1        Increasing Acceptance of Automation in Immunohistochemistry

    5.5       Impact Analysis

    6.             Immunohistochemistry Market – SAM Analysis

    6.1       SAM Immunohistochemistry Market Revenue Forecast and Analysis

    7.             SAM Immunohistochemistry Market Analysis– By Product

    7.1       Overview

    7.2       SAM Immunohistochemistry Market, By Product 2021 & 2028 (%)

    7.3       Antibodies

    7.3.1        Overview

    7.3.2        Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    7.3.3        Primary Antibodies

    7.3.3.1      Overview

    7.3.3.2      Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    7.3.4        Secondary Antibodies

    7.3.4.1      Overview

    7.3.4.2      Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    7.4       Equipment Market

    7.4.1        Overview

    7.4.2        Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    7.4.3        Slide Staining Systems

    7.4.3.1      Overview

    7.4.3.2      Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    7.4.4        Tissue Microarrays

    7.4.4.1      Overview

    7.4.4.2      Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    7.4.5        Tissue Processing Systems

    7.4.5.1      Overview

    7.4.5.2      Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    7.4.6        Slide Scanners

    7.4.6.1      Overview

    7.4.6.2      Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    7.4.7        Other Equipments

    7.4.7.1      Overview

    7.4.7.2      Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    7.5       Reagents Market

    7.5.1        Overview

    7.5.2        Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    7.5.3        Histological Stains

    7.5.3.1      Overview

    7.5.3.2      Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    7.5.4        Blocking Sera & Reagents Market

    7.5.4.1      Overview

    7.5.4.2      Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    7.5.5        Chromogenic Substrates Market

    7.5.5.1      Overview

    7.5.5.2      Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    7.5.6        Stabilizers

    7.5.6.1      Overview

    7.5.6.2      Stabilizers Market Revenue and Forecasts to 2028 (US$ Mn)

    7.5.7        Proteolytic Enzymes

    7.5.7.1      Overview

    7.5.7.2      Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    7.5.8        Organic Solvents

    7.5.8.1      Overview

    7.5.8.2      Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    7.5.9        Fixation Reagents

    7.5.9.1      Overview

    7.5.9.2      Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    7.5.10     Diluents

    7.5.10.1    Overview

    7.5.10.2    Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    7.6       Kits Market

    7.6.1        Overview

    7.6.2        Kits: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    8.             SAM Immunohistochemistry Market Analysis – By Application

    8.1       Overview

    8.2       SAM Immunohistochemistry Market Share by Application 2021 & 2028 (%)

    8.3       Diagnostics

    8.3.1        Overview

    8.3.2        Diagnostics Market Revenue and Forecast to 2028 (US$ Mn)

    8.3.3        Cancer

    8.3.3.1      Overview

    8.3.3.2      Cancer Market Revenue and Forecast to 2028 (US$ Mn)

    8.3.4        Infectious Diseases

    8.3.4.1      Overview

    8.3.4.2      Infectious Diseases Market Revenue and Forecast to 2028 (US$ Mn)

    8.3.5        Autoimmune Diseases

    8.3.5.1      Overview

    8.3.5.2      Autoimmune Diseases Market Revenue and Forecast to 2028 (US$ Mn)

    8.3.6        Diabetes Mellitus

    8.3.6.1      Overview

    8.3.6.2      Diabetes Mellitus Market Revenue and Forecast to 2028 (US$ Mn)

    8.3.7        Nephrological Diseases

    8.3.7.1      Overview

    8.3.7.2      Nephrological Diseases Market Revenue and Forecast to 2028 (US$ Mn)

    8.3.8        Others

    8.3.8.1      Overview

    8.3.8.2      Others Market Revenue and Forecast to 2028 (US$ Mn)

    8.4       Drug Testing

    8.4.1        Overview

    8.4.2        Drug Testing Market Revenue and Forecast to 2028 (US$ Mn)

    9.             SAM Immunohistochemistry Market Analysis– By End User

    9.1       Overview

    9.2       SAM Immunohistochemistry Market, By End User 2021 & 2028 (%)

    9.3       Hospital & Diagnostic Laboratories

    9.3.1        Overview

    9.3.2        Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    9.4       Research Institutes

    9.4.1        Overview

    9.4.2        Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    9.5       Others

    9.5.1        Overview

    9.5.2        Others: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    10.          SAM Immunohistochemistry Market – Country Analysis

    10.1    SAM Immunohistochemistry Market Revenue and Forecasts To 2028

    10.1.1     SAM Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)

    10.1.1.1    Argentina Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    10.1.1.1.1    Argentina Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    10.1.1.1.2    Argentina Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    10.1.1.1.2.1        Argentina Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)

    10.1.1.1.2.2        Argentina Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    10.1.1.1.2.3        Argentina Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)

    10.1.1.1.3    Argentina Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)

    10.1.1.1.3.1        Argentina Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)

    10.1.1.1.4    Argentina Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

    10.1.1.2    Brazil Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    10.1.1.2.1    Brazil Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    10.1.1.2.2    Brazil Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    10.1.1.2.2.1        Brazil Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)

    10.1.1.2.2.2        Brazil Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    10.1.1.2.2.3        Brazil Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)

    10.1.1.2.3    Brazil Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)

    10.1.1.2.3.1        Brazil Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)

    10.1.1.2.4    Brazil Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

    10.1.1.3    Rest of SAM: Immunohistochemistry Market– Revenue and Forecast to 2028 (USD Mn)

    10.1.1.3.1    Rest of SAM: Immunohistochemistry Market– Revenue and Forecast to 2028 (USD Mn)

    10.1.1.3.2    Rest of SAM Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    10.1.1.3.2.1        Rest of SAM Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)

    10.1.1.3.2.2        Rest of SAM Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    10.1.1.3.2.3        Rest of SAM Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)

    10.1.1.3.3    Rest of SAM Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)

    10.1.1.3.3.1        Rest of SAM Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)

    10.1.1.3.4    Rest of SAM Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

    11.          Impact Of COVID-19 Pandemic on SAM Immunohistochemistry Market

    11.1    SAM: Impact Assessment of COVID-19 Pandemic

    12.          Industry Landscape

    12.1    Overview

    12.2    Organic Developments

    12.2.1     Overview

    12.3    Inorganic developments

    12.3.1     Overview

    13.          Company Profiles

    13.1    F. HOFFMANN-LA ROCHE LTD.

    13.1.1     Key Facts

    13.1.2     Business Description

    13.1.3     Products and Services

    13.1.4     Financial Overview

    13.1.5     SWOT Analysis

    13.1.6     Key Developments

    13.2    MERCK KGaA

    13.2.1     Key Facts

    13.2.2     Business Description

    13.2.3     Products and Services

    13.2.4     Financial Overview

    13.2.5     SWOT Analysis

    13.2.6     Key Developments

    13.3    PerkinElmer Inc.

    13.3.1     Key Facts

    13.3.2     Business Description

    13.3.3     Products and Services

    13.3.4     Financial Overview

    13.3.5     SWOT Analysis

    13.3.6     Key Developments

    13.4    THERMO FISHER SCIENTIFIC INC.

    13.4.1     Key Facts

    13.4.2     Business Description

    13.4.3     Products and Services

    13.4.4     Financial Overview

    13.4.5     SWOT Analysis

    13.4.6     Key Developments

    13.5    Abcam plc

    13.5.1     Key Facts

    13.5.2     Business Description

    13.5.3     Products and Services

    13.5.4     Financial Overview

    13.5.5     SWOT Analysis

    13.5.6     Key Developments

    13.6    Agilent Technologies, Inc.

    13.6.1     Key Facts

    13.6.2     Business Description

    13.6.3     Products and Services

    13.6.4     Financial Overview

    13.6.5     SWOT Analysis

    13.6.6     Key Developments

    13.7    BIO-RAD LABORATORIES INC.

    13.7.1     Key Facts

    13.7.2     Business Description

    13.7.3     Products and Services

    13.7.4     Financial Overview

    13.7.5     SWOT Analysis

    13.7.6     Key Developments

    13.8    Danaher

    13.8.1     Key Facts

    13.8.2     Business Description

    13.8.3     Products and Services

    13.8.4     Financial Overview

    13.8.5     SWOT Analysis

    13.8.6     Key Developments

    13.9    Bio SB

    13.9.1     Key Facts

    13.9.2     Business Description

    13.9.3     Products and Services

    13.9.4     Financial Overview

    13.9.5     SWOT Analysis

    13.9.6     Key Developments

    14.          Appendix

    14.1    About The Insight Partners

    14.2    Glossary of Terms

    LIST OF TABLES

    Table 1.             SAM Immunohistochemistry Market – Revenue and Forecast to 2028 (USD Million)

    Table 2.             Argentina Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    Table 3.             Argentina Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

    Table 4.             Argentina Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    Table 5.             Argentina Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

    Table 6.             Argentina Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)

    Table 7.             Argentina Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)

    Table 8.             Argentina Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

    Table 9.             Brazil Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    Table 10.          Brazil Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

    Table 11.          Brazil Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    Table 12.          Brazil Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

    Table 13.          Brazil Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)

    Table 14.          Brazil Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)

    Table 15.          Brazil Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

    Table 16.          Rest of SAM Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    Table 17.          Rest of SAM Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

    Table 18.          Rest of SAM Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

    Table 19.          Rest of SAM Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

    Table 20.          Rest of SAM Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)

    Table 21.          Rest of SAM Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)

    Table 22.          Rest of SAM Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

    Table 23.          Organic Developments Done By Companies

    Table 24.          Inorganic developments done by Companies

    Table 25.          Glossary of Terms

    LIST OF FIGURES

    Figure 1.           SAM Immunohistochemistry Market Segmentation

    Figure 2.           SAM Immunohistochemistry Market Segmentation, By Country

    Figure 3.           SAM Immunohistochemistry Market Overview

    Figure 4.           Antibodies Segment Held the Largest Share of the Market in 2021

    Figure 5.           Brazil to Show Significant Growth During Forecast Period

    Figure 6.           SAM PEST Analysis

    Figure 7.           Impact Analysis of Drivers and Restraints Pertaining to SAM Immunohistochemistry Market

    Figure 8.           SAM Immunohistochemistry Market – Revenue Forecast and Analysis

    Figure 9.           SAM Immunohistochemistry Market, by Product 2021 & 2028 (%)

    Figure 10.        SAM Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 11.        SAM Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 12.        SAM Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 13.        SAM Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 14.        SAM Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 15.        SAM Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 16.        SAM Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 17.        SAM Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 18.        SAM Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 19.        SAM Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 20.        SAM Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 21.        SAM Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 22.        SAM Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 23.        SAM Stabilizer: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 24.        SAM Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 25.        SAM Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 26.        SAM Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 27.        SAM Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 28.        SAM Kits: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 29.        SAM Immunohistochemistry Market Share by Application 2021 & 2028 (%)

    Figure 30.        SAM Diagnostics Market Revenue and Forecasts To 2028 (US$ Mn)

    Figure 31.        SAM Cancer Market Revenue and Forecasts To 2028 (US$ Mn)

    Figure 32.        SAM Infectious Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

    Figure 33.        SAM Autoimmune Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

    Figure 34.        SAM Diabetes mellitus Market Revenue and Forecasts To 2028 (US$ Mn)

    Figure 35.        SAM Nephrological Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

    Figure 36.        SAM Others Market Revenue and Forecasts To 2028 (US$ Mn)

    Figure 37.        SAM Drug Testing Market Revenue and Forecasts To 2028 (US$ Mn)

    Figure 38.        SAM Immunohistochemistry Market, by End User 2021 & 2028 (%)

    Figure 39.        SAM Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 40.        SAM Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 41.        SAM Others: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 42.        SAM Immunohistochemistry Market Revenue Overview, by Country, 2021 (US$ Mn)

    Figure 43.        SAM Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)

    Figure 44.        Argentina Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 45.        Brazil Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 46.        Rest of SAM: Immunohistochemistry Market– Revenue and Forecast to 2028 (USD Mn)

    Figure 47.        Impact Of COVID-19 Pandemic in SAM Country Markets

    1. Abcam plc
    2. Agilent Technologies, Inc.
    3. Bio SB
    4. BIO-RAD LABORATORIES INC.
    5. Danaher
    6. F. HOFFMANN-LA ROCHE LTD.
    7. MERCK KGaA
    8. PerkinElmer Inc. 
    9. THERMO FISHER SCIENTIFIC INC.    
    • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the SAM immunohistochemistry market.        
    • Highlights key business priorities in order to assist companies to realign their business strategies
    • The key findings and recommendations highlight crucial progressive industry trends in the SAM immunohistochemistry market, thereby allowing players across the value chain to develop effective long-term strategies  
    • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
    • Scrutinize in-depth SAM market trends and outlook coupled with the factors driving the immunohistochemistry market, as well as those hindering it
    • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution  
    Report Code
    Full Name
    Country Name
    Email Id
    Phone Number
    Job Title
    Company
    Requirement

    Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


    Purchase Options
    Single User License
    $3000
    $1800
    Site License
    $4000
    $2400
    Enterprise License
    $5000
    $3000